| 摘要 |
The present invention relates to antibody molecules, in particular antibody molecules that bind Transforming Growth Factor beta (TGFbeta), and uses thereof. More particularly, the invention relates to antibody molecules that bind and preferably neutralise TGFbeta1, TGFbeta2 and TGFbeta3, so-called "pan-specific" antibody molecules, and uses of such antibody molecules. Preferred embodiments within the present invention are antibody molecules, whether whole antibody (e.g. IgG, such as IgG1 or IgG4) or antibody fragments (e.g. scFv, Fab, dAb).
|
